• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB

PATRYS LIMITED

33.3% ! 0.1¢
Market Cap $2.057M  !

Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating... Patrys Limited is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company’s deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). It has developed two humanized forms of deoxymab 3E10, both have improved activity over the original deoxymab 3E10 antibody. PAT-DX1 is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, while PAT-DX3 is a full-sized IgG antibody. In a range of pre-clinical studies, PAT-DX1 has shown an ability to kill cancer cells in cell models, human tumor explants, xenograft and orthotopic models. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. This allows specific delivery of cancer drugs to multiple types of cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAB 12/06/25 18 5.2K
12/06/25 Last post  mattyedw Comments Created with Sketch.  18  Views Created with Sketch.  5.2K 
PAB 11/06/25 48 16K
11/06/25 Last post  Thejerry01 Comments Created with Sketch.  48  Views Created with Sketch.  16K 
PAB
Positions on Board of Directors for sale: $50k or near offer
10/06/25 0 254
10/06/25 Last post  Raffout Comments Created with Sketch.  0  Views Created with Sketch.  254 
PAB 10/06/25 0 228
10/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  228 
PAB 10/06/25 0 169
10/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  169 
PAB 10/06/25 0 175
10/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  175 
PAB 10/06/25 0 150
10/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
PAB 10/06/25 0 186
10/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 

See All Discussions arrow Created with Sketch.

Timeline

Reinstatement to Official Quotation
10 Jun 17:47
 
Proposed issue of securities - PAB
10 Jun 17:46
 
Proposed issue of securities - PAB
10 Jun 17:46
 
Proposed issue of securities - PAB
10 Jun 17:46
 
Proposed issue of securities - PAB
10 Jun 17:46
 
Proposed issue of securities - PAB
10 Jun 17:46
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.1¢
Change
-0.001(33.3%)
Mkt cap ! $2.057M
Open High Low Value Volume
0.1¢ 0.2¢ 0.1¢ $2.948K 2.748M

Buyers (Bids)

No. Vol. Price($)
18 40935983 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 34677092 12
View Market Depth
Last trade - 15.47pm 13/06/2025 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.